title: Is sulfadiazine alone equivalent (benefit and harm) to spiramycin to treat acute toxoplasmosis in the first trimester of pregnancy?
authors: Associação Médica Brasileira, Brazil.
authors: Wanderley Marques
authors: WM
authors: Bernardo
authors: Faculdade de Medicina, Centro Universitário Lusíada, Santos, SP, Brazil.
authors: Miriam
authors: M
authors: Chinzon
authors: Faculdade de Medicina, Centro Universitário Lusíada, Santos, SP, Brazil.
authors: Felipe Galvão Batista
authors: FG
authors: Chaves
mesh_terms: D000208:Acute Disease; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000379:methods; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy*; D011261:Pregnancy Trimester, First; D015572:Spiramycin / Q000627:therapeutic use*; D013411:Sulfadiazine / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000188:drug therapy*; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy
chemical_list: D000890:Anti-Infective Agents; D013411:Sulfadiazine; D015572:Spiramycin; D002955:Leucovorin